Impact of sex and ozone exposure on the course of pneumonia in wild type and SP-A (-/-) mice

Microbial Pathogenesis

Volumn 52, Issue 4, 2012, Pages 239-249

  Mikerov, Anatoly N ^a,b   Hu, Sanmei ^a   Durrani, Faryal ^a   Gan, Xiaozhuang ^a,c   Wang, Guirong ^a,d   Umstead, Todd M ^a   Phelps, David S ^a   Floros, Joanna ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b SARATOV STATE MEDICAL UNIVERSITY   (Russian Federation)

^c CAPITAL INSTITUTE OF PEDIATRICS   (China)

^d State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

CFU; Cortisol; Hormones; Lung inflammation; Pneumonia infection; Spleen

Indexed keywords

HYDROCORTISONE; OZONE; SEX HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; COLONY FORMING UNIT; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; HYDROCORTISONE BLOOD LEVEL; KLEBSIELLA PNEUMONIAE; LUNG CLEARANCE; LUNG WEIGHT; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PNEUMONIA; PRIORITY JOURNAL; SEX DIFFERENCE; SPLEEN WEIGHT; TISSUE CHARACTERIZATION; WEIGHT GAIN; WILD TYPE;

AIR POLLUTANTS; ANIMALS; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LUNG; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORGAN SIZE; OZONE; PNEUMONIA; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; SEX FACTORS; SPLEEN;

BACTERIA (MICROORGANISMS); KLEBSIELLA PNEUMONIAE; MUS;

EID: 84862799086     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2012.01.005     Document Type: Article

References (70)

1. Kofteridis D.P., Papadakis J.A., Bouros D., Nikolaides P., Kioumis G., Levidiotou S., et al. Nosocomial lower respiratory tract infections: prevalence and risk factors in 14 Greek hospitals. Eur J Clin Microbiol Infect Dis 2004, 23(12):888-891.
2. Podschun R., Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 1998, 11(4):589-603.
3. Yinnon A.M., Butnaru A., Raveh D., Jerassy Z., Rudensky B. Klebsiella bacteraemia: community versus nosocomial infection. Qjm 1996, 89(12):933-941.
4. Anderson D.J., Richet H., Chen L.F., Spelman D.W., Hung Y.J., Huang A.T., et al. Seasonal variation in Klebsiella pneumoniae bloodstream infection on 4 continents. J Infect Dis 2008, 197(5):752-756.
5. Nielsen H.C. Testosterone regulation of sex differences in fetal lung development. Proc Soc Exp Biol Med 1992, 199(4):446-452.
6. Perelman R.H., Palta M., Kirby R., Farrell P.M. Discordance between male and female deaths due to the respiratory distress syndrome. Pediatrics 1986, 78(2):238-244.
7. Caracta C.F. Gender differences in pulmonary disease. Mt Sinai J Med 2003, 70(4):215-224.
8. Gordon H.S., Rosenthal G.E. The relationship of gender and in-hospital death: increased risk of death in men. Med Care 1999, 37(3):318-324.
9. Gutierrez F., Masia M., Mirete C., Soldan B., Rodriguez J.C., Padilla S., et al. The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens. J Infect 2006, 53(3):166-174.
10. Gannon C.J., Pasquale M., Tracy J.K., McCarter R.J., Napolitano L.M. Male gender is associated with increased risk for postinjury pneumonia. Shock 2004, 21(5):410-414.
11. Loeb M., McGeer A., McArthur M., Walter S., Simor A.E. Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med 1999, 159(17):2058-2064.
12. Yancey A.L., Watson H.L., Cartner S.C., Simecka J.W. Gender is a major factor in determining the severity of mycoplasma respiratory disease in mice. Infect Immun 2001, 69(5):2865-2871.
13. Yamamoto Y., Saito H., Setogawa T., Tomioka H. Sex differences in host resistance to Mycobacterium marinum infection in mice. Infect Immun 1991, 59(11):4089-4096.
14. Ashman R.B., Kay P.H., Lynch D.M., Papadimitriou J.M. Murine candidiasis: sex differences in the severity of tissue lesions are not associated with levels of serum C3 and C5. Immunol Cell Biol 1991, 69(Pt 1):7-10.
15. Huber S.A., Job L.P., Auld K.R. Influence of sex hormones on Coxsackie B-3 virus infection in Balb/c mice. Cell Immunol 1982, 67(1):173-179.
16. Bernstein J.A., Alexis N., Barnes C., Bernstein I.L., Bernstein J.A., Nel A., et al. Health effects of air pollution. J Allergy Clin Immunol 2004, 114(5):1116-1123.
17. McBride D.E., Koenig J.Q., Luchtel D.L., Williams P.V., Henderson W.R. Inflammatory effects of ozone in the upper airways of subjects with asthma. Am J Respir Crit Care Med 1994, 149(5):1192-1197.
18. Currie W.D., van Schaik S., Vargas I., Enhorning G. Breathing and pulmonary surfactant function in mice 24 h after ozone exposure. Eur Respir J 1998, 12(2):288-293.
19. Kehrl H.R., Vincent L.M., Kowalsky R.J., Horstman D.H., O'Neil J.J., McCartney W.H., et al. Ozone exposure increases respiratory epithelial permeability in humans. Am Rev Respir Dis 1987, 135(5):1124-1128.
20. Hollingsworth J.W., Kleeberger S.R., Foster W.M. Ozone and pulmonary innate immunity. Proc Am Thorac Soc 2007, 4(3):240-246.
21. Yang W., Omaye S.T. Air pollutants, oxidative stress and human health. Mutat Res 2009, 674(1-2):45-54.
22. Carey M.A., Card J.W., Voltz J.W., Germolec D.R., Korach K.S., Zeldin D.C. The impact of sex and sex hormones on lung physiology and disease: lessons from animal studies. Am J Physiol Lung Cell Mol Physiol 2007.
23. Annesi-Maesano I., Agabiti N., Pistelli R., Couilliot M.F., Forastiere F. Subpopulations at increased risk of adverse health outcomes from air pollution. Eur Respir J Suppl 2003, 40:57s-63s.
24. Carey M.A., Card J.W., Voltz J.W., Arbes S.J., Germolec D.R., Korach K.S., et al. It's all about sex: gender, lung development and lung disease. Trends Endocrinol Metab 2007, 18(8):308-313.
25. Wright J.R., Youmans D.C. Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophage. Am J Physiol Lung Cell Mol Physiol 1993, 264(4 Pt 1):L338-L344.
26. Mikerov A.N., Umstead T.M., Huang W., Liu W., Phelps D.S., Floros J. SP-A1 and SP-A2 variants differentially enhance association of Pseudomonas aeruginosa with rat alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 2005, 288(1):L150-L158.
27. Ding J., Umstead T.M., Floros J., Phelps D.S. Factors affecting SP-A-mediated phagocytosis in human monocytic cell lines. Respir Med 2004, 98(7):637-650.
28. Mikerov A.N., Wang G., Umstead T.M., Zacharatos M., Thomas N.J., Phelps D.S., et al. Surfactant protein A2 (SP-A2) variants expressed in CHO cells stimulate phagocytosis of Pseudomonas aeruginosa more than Do SP-A1 variants. Infect Immun 2007, 75(3):1403-1412.
29. Mariencheck W.I., Savov J., Dong Q., Tino M.J., Wright J.R. Surfactant protein A enhances alveolar macrophage phagocytosis of a live, mucoid strain of P. aeruginosa. Am J Physiol Lung Cell Mol Physiol 1999, 277(4 Pt 1):L777-L786.
30. Khubchandani K.R., Oberley R.E., Snyder J.M. Effects of surfactant protein A and NaCl concentration on the uptake of Pseudomonas aeruginosa by THP-1 cells. Am J Respir Cell Mol Biol 2001, 25(6):699-706.
31. Borron P., McCormack F.X., Elhalwagi B.M., Chroneos Z.C., Lewis J.F., Zhu S., et al. Surfactant protein A inhibits T cell proliferation via its collagen-like tail and a 210-kDa receptor. Am J Physiol Lung Cell Mol Physiol 1998, 275(4 Pt 1):L679-L686.
32. Kremlev S.G., Umstead T.M., Phelps D.S. Effects of surfactant protein A and surfactant lipids on lymphocyte proliferation in vitro. Am J Physiol Lung Cell Mol Physiol 1994, 267(4 Pt 1):L357-L364.
33. Brinker K.G., Garner H., Wright J.R. Surfactant protein A modulates the differentiation of murine bone marrow-derived dendritic cells. American journal of physiology 2003, 284(1):L232-L241.
34. Kremlev S.G., Phelps D.S. Surfactant protein A stimulation of inflammatory cytokine and immunoglobulin production. Am J Physiol Lung Cell Mol Physiol 1994, 267(6 Pt 1):L712-L719.
35. Wang G., Phelps D.S., Umstead T.M., Floros J. Human SP-A protein variants derived from one or both genes stimulate TNF-alpha production in the THP-1 cell line. Am J Physiol Lung Cell Mol Physiol 2000, 278(5):L946-L954.
36. Wang G., Umstead T.M., Phelps D.S., Al-Mondhiry H., Floros J. The effect of ozone exposure on the ability of human surfactant protein A variants to stimulate cytokine production. Environ Health Perspect 2002, 110(1):79-84.
37. Borron P., McIntosh J.C., Korfhagen T.R., Whitsett J.A., Taylor J., Wright J.R. Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo. Am J Physiol Lung Cell Mol Physiol 2000, 278(4):L840-L847.
38. Koptides M., Umstead T.M., Floros J., Phelps D.S. Surfactant protein A activates NF-kappa B in the THP-1 monocytic cell line. Am J Physiol 1997, 273(2 Pt 1):L382-L388.
39. Song M., Phelps D.S. Interaction of surfactant protein A with lipopolysaccharide and regulation of inflammatory cytokines in the THP-1 monocytic cell line. Infection and immunity 2000, 68(12):6611-6617.
40. LeVine A.M., Kurak K.E., Bruno M.D., Stark J.M., Whitsett J.A., Korfhagen T.R. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol 1998, 19(4):700-708.
41. LeVine A.M., Bruno M.D., Huelsman K.M., Ross G.F., Whitsett J.A., Korfhagen T.R. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. J Immunol 1997, 158(9):4336-4340.
42. LeVine A.M., Whitsett J.A., Gwozdz J.A., Richardson T.R., Fisher J.H., Burhans M.S., et al. Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J Immunol 2000, 165(7):3934-3940.
43. Mikerov A.N., Haque R., Gan X., Guo X., Phelps D.S., Floros J. Ablation of SP-A has a negative impact on the susceptibility of mice to Klebsiella pneumoniae infection after ozone exposure: sex differences. Respir Res 2008, 9:77.
44. Peel J.L., Tolbert P.E., Klein M., Metzger K.B., Flanders W.D., Todd K., et al. Ambient air pollution and respiratory emergency department visits. Epidemiology 2005, 16(2):164-174. Cambridge, Mass.
45. Kennedy S.M., Chambers R., Du W., Dimich-Ward H. Environmental and occupational exposures: do they affect chronic obstructive pulmonary disease differently in women and men?. Proc Am Thorac Soc 2007, 4(8):692-694.
46. Jarvis D., Chinn S., Sterne J., Luczynska C., Burney P. The association of respiratory symptoms and lung function with the use of gas for cooking. Eur Respir J 1998, 11(3):651-658. European Community Respiratory Health Survey.
47. Schwela D. Air pollution and health in urban areas. Rev Environ Health 2000, 15(1-2):13-42.
48. Dow L., Fowler L., Phelps L., Waters K., Coggon D., Kinmonth A.L., et al. Prevalence of untreated asthma in a population sample of 6000 older adults in Bristol, UK. Thorax 2001, 56(6):472-476.
49. Peters J.M., Avol E., Gauderman W.J., Linn W.S., Navidi W., London S.J., et al. A study of twelve Southern California communities with differing levels and types of air pollution. II. Effects on pulmonary function. Am J Respir Crit Care Med 1999, 159(3):768-775.
50. Li Y.F., Gilliland F.D., Berhane K., McConnell R., Gauderman W.J., Rappaport E.B., et al. Effects of in utero and environmental tobacco smoke exposure on lung function in boys and girls with and without asthma. Am J Respir Crit Care Med 2000, 162(6):2097-2104.
51. Medina-Ramon M., Schwartz J. Who is more vulnerable to die from ozone air pollution?. Epidemiology 2008, 19(5):672-679. Cambridge, Mass.
52. Bates D.V. The effects of air pollution on children. Environ Health Perspect 1995, 103(Suppl 6):49-53.
53. Wang L., Lubin J.H., Zhang S.R., Metayer C., Xia Y., Brenner A., et al. Lung cancer and environmental tobacco smoke in a non-industrial area of China. Int J Cancer 2000, 88(1):139-145.
54. Oosterlee A., Drijver M., Lebret E., Brunekreef B. Chronic respiratory symptoms in children and adults living along streets with high traffic density. Occup Environ Med 1996, 53(4):241-247.
55. Abbey D.E., Nishino N., McDonnell W.F., Burchette R.J., Knutsen S.F., Lawrence Beeson W., et al. Long-term inhalable particles and other air pollutants related to mortality in nonsmokers. Am J Respir Crit Care Med 1999, 159(2):373-382.
56. Dockery D.W., Pope C.A., Xu X., Spengler J.D., Ware J.H., Fay M.E., et al. An association between air pollution and mortality in six U.S. cities. N Engl J Med 1993, 329(24):1753-1759.
57. Mikerov A.N., Gan X., Umstead T.M., Miller L., Chinchilli V.M., Phelps D.S., et al. Sex differences in the impact of ozone on survival and alveolar macrophage function of mice after Klebsiella pneumoniae infection. Respir Res 2008, 9:24.
58. Zellweger R., Wichmann M.W., Ayala A., Stein S., DeMaso C.M., Chaudry I.H. Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males. Crit Care Med 1997, 25(1):106-110.
59. Wichmann M.W., Ayala A., Chaudry I.H. Male sex steroids are responsible for depressing macrophage immune function after trauma-hemorrhage. Am J Physiol 1997, 273(4 Pt 1):C1335-C1340.
60. Wichmann M.W., Zellweger R., DeMaso C.M., Ayala A., Chaudry I.H. Enhanced immune responses in females, as opposed to decreased responses in males following haemorrhagic shock and resuscitation. Cytokine 1996, 8(11):853-863.
61. Durrani F., Phelps D.S., Weisz J., Silveyra P., Hu S., Mikerov A.N., et al. Gonadal hormones and oxidative stress interaction differentially affects survival of male and female mice after lung Klebsiella pneumoniae infection. Exp Lung Res 2012, in press.
62. Mikerov A.N., Cooper T.K., Wang G., Hu S., Umstead T.M., Phelps D.S., et al. Histopathologic evaluation of lung and extrapulmonary tissues show sex differences in Klebsiella pneumoniae - infected mice under different exposure conditions. Int J Physiol Pathophysiol Pharmacol 2011, 3(3):176-190.
63. Wang X. Lipopolysaccharide augments venous and arterial thrombosis in the mouse. Thromb Res 2008, 123(2):355-360.
64. Card J.W., Zeldin D.C. Hormonal influences on lung function and response to environmental agents: lessons from animal models of respiratory disease. Proc Am Thorac Soc 2009, 6(7):588-595.
65. Elenkov I.J., Chrousos G.P. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci 2002, 966:290-303.
66. Blotta M.H., DeKruyff R.H., Umetsu D.T. Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. J Immunol 1997, 158(12):5589-5595.
67. Wilckens T., De Rijk R. Glucocorticoids and immune function: unknown dimensions and new frontiers. Immunol today 1997, 18(9):418-424.
68. Spellberg B., Edwards J.E. Type 1/Type 2 immunity in infectious diseases. Clin Infect Dis 2001, 32(1):76-102.
69. Agarwal S.K., Marshall G.D. Glucocorticoid-induced type 1/type 2 cytokine alterations in humans: a model for stress-related immune dysfunction. J Interferon Cytokine Res 1998, 18(12):1059-1068.
70. Haque R., Umstead T.M., Ponnuru P., Guo X., Hawgood S., Phelps D.S., et al. Role of surfactant protein-A (SP-A) in lung injury in response to acute ozone exposure of SP-A deficient mice. Toxicol Appl Pharmacol 2007, 220(1):72-82.